Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

on General Well-being, Anxiety, and Physical Activity in Pregnant Women

NCT07023978 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-12-15
Last updated
2025-08-07

Condition(s) studied

Pregnancy

Investigational drug(s) / intervention(s)

Some movements in the qigong study called Ba Duan Jin, which will be applied to pregnant women, will be arranged for pregnant women and explained in detail. These are very slow, movements

Some movements in the qigong study called Ba Duan Jin, which will be applied to pregnant women, will be arranged for pregnant women and explained in detail. These are very slow, movements: Ba Duan Jin Qigong

Study summary

102 pregnant women will be randomly divided into 2 groups. Participants in the control group will be given pregnancy counseling that includes only nutrition, walking (3 days a week for 30 minutes), and breathing exercises, and will be called for 1st, 2nd and 3rd month check-ups. In addition to pregnancy counseling, the Qigong group will receive 2 Qigong training sessions, one via Zoom and one face-to-face, and then the training videos of each exercise will be sent via WhatsApp. Paricipants will be asked to do the Qigong exercises at home for 30 minutes, 3 days a week for 12 weeks. These participants will be called for 1-month, 2-month and 3-month check-ups. Blood pressure and sugar measurements will be recorded at the first visit, 1st month, 2nd month and 3rd month check-ups, and patients will also be evaluated with the Pregnancy Physical Activity Questionnaire, Pregnancy Stress Assessment Scale, Pregnancy-related Anxiety Scale, Pregnancy Exercise Self-Efficacy Questionnaire. After the recruitment period the results will be evaluated statistically.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Pregnant women between the ages of 18-40 who have a new pregnancy detected by USG * Pregnant women whose pregnancy week is compatible with fetal development, who do not have any problems and who will not have any problems exercising Exclusion Criteria: * Those with risky pregnancies (cervical dilation, bleeding, premature membrane rupture, etc.) \*\<18 and \>40 years old pregnant women * Those with cardiovascular disease or hypertension * Those with uncontrolled diabetes * Those with uncontrolled thyroid disease * Those with a previous risky pregnancy or a complication * Those with an operation, metabolic bone disease or joint limitation that will prevent them from exercising * Those who are included in another pregnancy counseling or physical activity program * Those who do not give their consent for the study, do not come to regular pregnancy check-ups or have incomplete information will be excluded from the study.

Primary outcome measure(s)

  • Blood Glucose Values — 2 minutes
    Glucose is the key metabolic substrate for tissue energy production. In the perinatal period the mother supplies glucose to the fetus and for most of the gestational period the normal lower limit of fetal glucose concentration is around 3 mmol/L. diabetes is high blood sugar (glucose) that develops during pregnancy and usually disappears after giving birth. It can happen at any stage of pregnancy, but is more common in the second or third trimester.
  • Pregnancy Exercise Self-Efficacy Scale — 10 minutes
    The Pregnancy Exercise Self-Efficacy Scale (P-ESES) is a validated tool designed to assess a pregnant woman's confidence in her ability to engage in physical activity during pregnancy. It measures self-efficacy across various situations that may influence exercise behavior, such as fatigue, lack of time, or discomfort. The scale typically includes a set of statements where respondents rate their confidence levels using a Likert-type scale (usually from 1 = not at all confident to 5 = completely confident). Higher total scores indicate greater self-efficacy regarding exercise during pregnancy. The final score is calculated by summing all item responses, and it helps identify women who may need additional support or encouragement to stay active.
  • blood pressure value — 2 minutes
    High blood pressure during pregnancy occurs when a pregnant woman has a blood pressure reading of 140/90 mm Hg or higher in two readings that are 4 or more hours apart. Severe high blood pressure during pregnancy occurs when a pregnant woman has a blood pressure reading of 160/110 mm Hg on two or more occasions

Trial sites (1)

FacilityCityRegionStatus
Home adress of the principal investigator Kocaeli Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07023978 on ClinicalTrials.gov ↗ ← All trials in Turkey